Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research to drive the future of innovation.

Press Releases

BIO Supports PDUFA VIII Commitment Letter and Urges Timely Reauthorization

August 13, 2026

Biotechnology Innovation Organization (BIO) Senior Vice President of Science & Regulatory Affairs Annetta Beauregard issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VIII commitment letter:“For more than 30 years, PDUFA has helped deliver hundreds of…

BIO Statement on Senate Reintroduction of the PASTEUR Act

June 24, 2026

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act in the Senate:“Moving the PASTEUR Act…

BIO International Convention Returns to San Diego to Celebrate Five Decades of Biotechnology

June 22, 2026

20,000+ biotech leaders gather with a shared mission: to improve lives SAN DIEGO (June 22, 2026) - The BIO International Convention (BIO 2026), the world’s largest and most comprehensive event for the biotechnology industry, begins today in San Diego. The convention brings together 20…